| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/09/2023 | 204.88% | Maxim Group | → $5 | Initiates Coverage On | → Buy |
| 05/31/2023 | 1119.51% | HC Wainwright & Co. | → $20 | Reiterates | Buy → Buy |
| 07/21/2022 | 265.85% | HC Wainwright & Co. | $11 → $6 | Maintains | Buy |
| 05/17/2022 | 204.88% | Cantor Fitzgerald | $11 → $5 | Maintains | Overweight |
| 04/28/2022 | 570.73% | HC Wainwright & Co. | $24 → $11 | Maintains | Buy |
| 03/30/2021 | 570.73% | Cantor Fitzgerald | → $11 | Initiates Coverage On | → Overweight |
| 05/29/2020 | 82.93% | HC Wainwright & Co. | → $3 | Initiates Coverage On | → Buy |
| 10/22/2018 | 509.76% | Northland Capital Markets | → $10 | Initiates Coverage On | → Outperform |
What is the target price for Aytu BioPharma (AYTU)?
The latest price target for Aytu BioPharma (NASDAQ: AYTU) was reported by Maxim Group on August 9, 2023. The analyst firm set a price target for $5.00 expecting AYTU to rise to within 12 months (a possible 204.88% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aytu BioPharma (AYTU)?
The latest analyst rating for Aytu BioPharma (NASDAQ: AYTU) was provided by Maxim Group, and Aytu BioPharma initiated their buy rating.
When is the next analyst rating going to be posted or updated for Aytu BioPharma (AYTU)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aytu BioPharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aytu BioPharma was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.
Is the Analyst Rating Aytu BioPharma (AYTU) correct?
While ratings are subjective and will change, the latest Aytu BioPharma (AYTU) rating was a initiated with a price target of $0.00 to $5.00. The current price Aytu BioPharma (AYTU) is trading at is $1.64, which is within the analyst's predicted range.